In order to find, create, and market innovative antibody-based therapies for rare illnesses, AbCellera and Rallybio…
Continue ReadingCategory: Trending News
Agilent Attains ‘Angel’ Level Sponsorship with My Green Lab
My Green Lab, a nonprofit organization devoted to fostering a global culture of sustainability in research,…
Continue Reading
IPA’s Subsidiary BioStrand and BriaCell Announce Artificial Intelligence Collaboration and License Agreement
IPA, a leading biotherapeutics research and technology company, announced that BioStrand BV for IPA’s AI in…
Continue Reading
Rocket Pharmaceuticals Completes Acquisition of Renovacor
Rocket Pharmaceuticals, Inc. a leading early-stage biotechnology company developing an integrated and sustainable gene therapy pipeline…
Continue Reading
Cimeio Therapeutics Announces Issuance of Key Patent Covering Cell Therapy Platform
Cimeio Therapeutics, a biotechnology company developing a new approach to cell therapy, today announced that the…
Continue Reading
Biocytogen Enters into Antibody Agreement with ADC Therapeutics
ADC Therapeutics SA and Biocytogen Pharmaceuticals Co., Ltd. announced that they had signed an assessment and…
Continue Reading
Avista Capital Partners acquires Taconic Biosciences
Private equity company Avista Capital Partners has acquired Taconic Biosciences, a provider of genetically engineered research…
Continue Reading
Proscia presents results on AI melanoma diagnostic predictions
Proscia has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma,…
Continue Reading
MycoWorks Secures Strategic Investment from GM Ventures to Develop Fine Mycelium Materials for Sustainable Automotive Interiors
The General Motors Co. investment arm, GM Ventures, and the biotechnology startup MycoWorks today announced a…
Continue Reading
Ginkgo Bioworks Completes Acquisition of Zymergen
Ginkgo Bioworks is the main flat stage for cell programming, and Zymergen reported that Ginkgo has…
Continue Reading